Skip to main content

Advertisement

SpringerLink
Log in

Changing Patterns of Antimicrobial Susceptibility of Invasive Pneumococcal Diseases after Introduction of Pneumococcal Conjugate Vaccine

  • Scientific Letter
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Centers for Disease Control and Prevention. Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006–2015. MMWR Morb Mortal Wkly Rep. 2006;55:511–5.

    Google Scholar 

  2. Ceyhan M, Gurler N, Yaman A, Ozturk C, Oksuz L, Ozkan S, et al. Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide. Clin Vaccine Immunol. 2011;18:1028–30.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Yalçin I, Gürler N, Alhan E, Yaman A, Turgut M, Celik U, et al. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001–2004. Eur J Pediatr. 2006;165:654–7.

    Article  PubMed  Google Scholar 

  4. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:197–209.

    Article  Google Scholar 

  5. Jefferies JM, Macdonald E, Faust SN, Clarke SC. 13-valent pneumococcal conjugate vaccine (PCV13). Hum Vaccine. 2011;7:1012–8.

    Article  CAS  Google Scholar 

Download references

Conflict of Interest

None.

Source of Funding

None.

Author information

Authors and Affiliations

  1. Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children’s Hospital, İzmir, Turkey

    Nuri Bayram, Hurşit Apa & İlker Devrim

  2. Department of Microbiology and Clinical Microbiology, Dr. Behçet Uz Children’s Hospital, İzmir, Turkey

    Gamze Gülfidan

  3. Department of Pediatrics, Dr. Behçet Uz Children’s Hospital, İzmir, Turkey

    İlker Günay & Nurettin Ünal

Authors
  1. Nuri Bayram
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hurşit Apa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gamze Gülfidan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. İlker Günay
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nurettin Ünal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. İlker Devrim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuri Bayram.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bayram, N., Apa, H., Gülfidan, G. et al. Changing Patterns of Antimicrobial Susceptibility of Invasive Pneumococcal Diseases after Introduction of Pneumococcal Conjugate Vaccine. Indian J Pediatr 81, 1124–1125 (2014). https://doi.org/10.1007/s12098-014-1485-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-014-1485-5

Keywords

Search

Navigation